Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Decarboxy Moxifloxacin

Copy Product Info
🥰Excellent
Catalog No. T10987Cas No. 1322062-57-6

Decarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxy quinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.

Decarboxy Moxifloxacin

Decarboxy Moxifloxacin

Copy Product Info
🥰Excellent
Purity: 99.65%
Catalog No. T10987Cas No. 1322062-57-6
Decarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxy quinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$38In StockIn Stock
5 mg$86In StockIn Stock
10 mg$128In StockIn Stock
25 mg$215In StockIn Stock
50 mg$320In StockIn Stock
100 mg$455In StockIn Stock
1 mL x 10 mM (in DMSO)$94In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.65%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Decarboxy Moxifloxacin AI Summary
Decarboxy Moxifloxacin shows antibacterial activity, with a minimum inhibitory concentration (MIC) of greater than 200.0 ug/mL against Escherichia coli KD65. It also demonstrates antibacterial activity with an MIC of 100.0 ug/mL against tolC knockout Escherichia coli KD1397. However, the compound exhibits an MIC of greater than 200.0 ug/mL against Mycobacterium smegmatis KD1163..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Decarboxylated moxifloxacin is a decarboxylated compound of moxifloxacin. Moxifloxacin is an oral active 8-methoxy quinolone antibiotic used in acute bacterial sinusitis, chronic bronchitis, acute bacterial deterioration, and community-acquired pneumonia.
Chemical Properties
Molecular Weight357.42
FormulaC20H24FN3O2
Cas No.1322062-57-6
SmilesO(C)C1=C2N(C=CC(=O)C2=CC(F)=C1N3C[C@]4([C@@](C3)(NCCC4)[H])[H])C5CC5
Relative Density.1.300 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 65 mg/mL (181.86 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7978 mL13.9891 mL27.9783 mL139.8914 mL
5 mM0.5596 mL2.7978 mL5.5957 mL27.9783 mL
10 mM0.2798 mL1.3989 mL2.7978 mL13.9891 mL
20 mM0.1399 mL0.6995 mL1.3989 mL6.9946 mL
50 mM0.0560 mL0.2798 mL0.5596 mL2.7978 mL
100 mM0.0280 mL0.1399 mL0.2798 mL1.3989 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Decarboxy Moxifloxacin | purchase Decarboxy Moxifloxacin | Decarboxy Moxifloxacin cost | order Decarboxy Moxifloxacin | Decarboxy Moxifloxacin chemical structure | Decarboxy Moxifloxacin formula | Decarboxy Moxifloxacin molecular weight